Insider Stock Trading History of Adams Adrian


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Adams Adrian since year 2005. The trader's CIK number is 1248144. At the time of this reporting, Adams Adrian is the Chief Executive Officer of Aralez Pharmaceuticals Inc. . (stock ticker symbol ARLZ). See this page for all insider trading activities at Aralez Pharmaceuticals Inc. .

Note that in the past ADAMS ADRIAN also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Adams Adrian since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-03-15 ARLZ Aralez Pharmaceuticals Inc. Buy 500,000 2.46 1,231,000
2015-11-11 POZN Pozen Inc /nc Buy 551,471 6.45 3,556,987
2015-11-12 POZN Pozen Inc /nc Buy 448,529 6.68 2,995,725
2014-12-05 AUXL Auxilium Pharmaceuticals Inc Option Ex 40,000 17.40 696,000
2014-12-05 AUXL Auxilium Pharmaceuticals Inc Sale 40,000 33.97 1,358,720
2013-05-24 ACRX Acelrx Pharmaceuticals Inc Buy 25,000 7.78 194,500
2013-05-28 ACRX Acelrx Pharmaceuticals Inc Buy 50,000 8.39 419,500
2012-12-14 AUXL Auxilium Pharmaceuticals Inc Buy 56,000 .00 0
2008-05-27 SEPR Sepracor Inc /de/ Buy 50,000 20.96 1,048,000
2005-08-16 KOSP Kos Pharmaceuticals Inc Sale 5,509 70.80 390,037
2005-08-16 KOSP Kos Pharmaceuticals Inc Sale 8,309 70.94 589,415
2005-07-19 KOSP Kos Pharmaceuticals Inc Sale 8,309 74.96 622,875
2005-06-21 KOSP Kos Pharmaceuticals Inc Sale 7,150 66.18 473,201
2005-05-17 KOSP Kos Pharmaceuticals Inc Sale 7,150 53.63 383,433
2005-04-19 KOSP Kos Pharmaceuticals Inc Sale 35,750 49.28 1,761,760

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Adams Adrian (Chief Executive Officer of Aralez Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.